174 related articles for article (PubMed ID: 35013128)
1. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Yin H; Zhang C; Wei Z; He W; Xu N; Xu Y; Li T; Ren K; Kuang Y; Zhu X; Yuan F; Yu H; Gou X
Cell Death Dis; 2022 Jan; 13(1):39. PubMed ID: 35013128
[TBL] [Abstract][Full Text] [Related]
2. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
Liu L; Yang Y; Liu S; Tao T; Cai J; Wu J; Guan H; Zhu X; He Z; Li J; Song E; Zeng M; Li M
Oncogene; 2019 Jan; 38(5):747-764. PubMed ID: 30177836
[TBL] [Abstract][Full Text] [Related]
3. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.
Shi W; Zhang G; Ma Z; Li L; Liu M; Qin L; Yu Z; Zhao L; Liu Y; Zhang X; Qin J; Ye H; Jiang X; Zhou H; Sun H; Jiao Z
Nat Commun; 2021 May; 12(1):2812. PubMed ID: 33990570
[TBL] [Abstract][Full Text] [Related]
4. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
5. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2 domain containing protein 5 (SH2D5) binds the breakpoint cluster region protein, BCR, and regulates levels of Rac1-GTP.
Gray EJ; Petsalaki E; James DA; Bagshaw RD; Stacey MM; Rocks O; Gingras AC; Pawson T
J Biol Chem; 2014 Dec; 289(51):35397-408. PubMed ID: 25331951
[TBL] [Abstract][Full Text] [Related]
7. The Role of Shcbp1 in Signaling and Disease.
Zhang GY; Ma ZJ; Wang L; Sun RF; Jiang XY; Yang XJ; Long B; Ye HL; Zhang SZ; Yu ZY; Shi WG; Jiao ZY
Curr Cancer Drug Targets; 2019; 19(11):854-862. PubMed ID: 31250756
[TBL] [Abstract][Full Text] [Related]
8. Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.
Dai Y; Hu C; Zhou H; Liu W; Lai W; Xu R; Liao J; Wang J; Li G; Zhang R
FEBS J; 2023 Dec; 290(24):5720-5743. PubMed ID: 37581853
[TBL] [Abstract][Full Text] [Related]
9. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
10. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
Yang C; Hu JF; Zhan Q; Wang ZW; Li G; Pan JJ; Huang L; Liao CY; Huang Y; Tian YF; Shen BY; Chen JZ; Wang YD; Chen S
Genomics; 2021 Mar; 113(2):827-842. PubMed ID: 33515675
[TBL] [Abstract][Full Text] [Related]
11. The Aurora-B-mediated phosphorylation of SHCBP1 regulates cytokinetic furrow ingression.
Asano E; Hasegawa H; Hyodo T; Ito S; Maeda M; Takahashi M; Hamaguchi M; Senga T
J Cell Sci; 2013 Aug; 126(Pt 15):3263-70. PubMed ID: 23704356
[TBL] [Abstract][Full Text] [Related]
12. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
13. DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.
Lai CH; Xu K; Zhou J; Wang M; Zhang W; Liu X; Xiong J; Wang T; Wang Q; Wang H; Xu T; Hu H
Cell Death Dis; 2020 Nov; 11(11):986. PubMed ID: 33203836
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
15. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells.
Sato K; Kimoto M; Kakumoto M; Horiuchi D; Iwasaki T; Tokmakov AA; Fukami Y
Genes Cells; 2000 Sep; 5(9):749-64. PubMed ID: 10971656
[TBL] [Abstract][Full Text] [Related]
16. SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway.
Ren C; Zhou Z; Wang X; Hua X; Zou M; Zhang X
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):136-143. PubMed ID: 32769441
[TBL] [Abstract][Full Text] [Related]
17. Temporal regulation of EGF signalling networks by the scaffold protein Shc1.
Zheng Y; Zhang C; Croucher DR; Soliman MA; St-Denis N; Pasculescu A; Taylor L; Tate SA; Hardy WR; Colwill K; Dai AY; Bagshaw R; Dennis JW; Gingras AC; Daly RJ; Pawson T
Nature; 2013 Jul; 499(7457):166-71. PubMed ID: 23846654
[TBL] [Abstract][Full Text] [Related]
18. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.
Izumi K; Zheng Y; Li Y; Zaengle J; Miyamoto H
Int J Oncol; 2012 Nov; 41(5):1587-92. PubMed ID: 22922989
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
